ENDOMET BIOSCIENCES, INC

EndoCyclic Therapeutics

Irvine, United States · Founded 2019 · $3.0M raised

Headquarters
Irvine, California
Employees
1–10
Founded
2019
Business Model
B2G
Total Funding
$3.0M
Last Round
$2.0M GrantApr 2025
Rounds
2

About

Endomet Biosciences (now EndoCyclic Therapeutics) is a biopharmaceutical company developing first-in-class non-hormonal therapeutics and diagnostics for endometriosis and oncology. Its lead program ENDO-205 is a pH-sensitive peptide therapeutic designed to eliminate endometriosis lesions without hormones or systemic toxicity, with FDA IND clearance obtained.

Summary

ENDOMET BIOSCIENCES, INC is a Biotech company based in Irvine, United States, founded in 2019. It has raised $3.0M in total across 2 rounds, most recently a $2.0M Grant round in Apr 2025. Investors include National Institute of Child Health and Human Development and Small Business Innovation Research.

Tech & App Stack

2 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

GrantApr 2025
$2.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ENDOMET BIOSCIENCES, INC on Indexed.vc
<a href="https://indexed.vc/companies/endomet-biosciences-inc"><img src="https://indexed.vc/api/badge/company/endomet-biosciences-inc" alt="ENDOMET BIOSCIENCES, INC on Indexed.vc" width="260" height="76" /></a>